Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

被引：0
|
作者：
Paul Emery
Marjolijn Van Keep
Steve Beard
Chris Graham
LaStella Miles
Steffen Marc Jugl
Praveen Gunda
Anna Halliday
Helena Marzo-Ortega
机构：
[1] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine
[2] NIHR Leeds Biomedical Research Centre,undefined
[3] Leeds Teaching Hospitals NHS Trust,undefined
[4] BresMed Netherlands BV,undefined
[5] BresMed,undefined
[6] RTI Health Solutions,undefined
[7] Novartis Pharma AG,undefined
[8] Novartis Healthcare Private Limited,undefined
[9] Novartis Pharmaceuticals UK Ltd,undefined
来源：
PharmacoEconomics | 2018年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1027
页数：12
相关论文
共 50 条
  • [41] Secukinumab for ankylosing spondylitis Authors' reply
    Baeten, Dominique
    Hueber, Wolfgang
    LANCET, 2014, 383 (9919): : 780 - 781
  • [42] Secukinumab for ankylosing spondylitis and psoriatic arthritis
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1587 - 1592
  • [43] Correction to: Secukinumab: A Review in Ankylosing Spondylitis
    Hannah A. Blair
    Drugs, 2019, 79 : 445 - 445
  • [44] Secukinumab Versus Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis from Korean Perspective
    Kim, Dam
    Kim, Hyojin
    Cho, Seongha
    Park, Min-Chan
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] A cost per responder analysis of secukinumab vs adalimumab for the treatment of ankylosing spondylitis from the Korean perspective
    Kim, Dam
    Kim, Hyojin
    Cho, SeongHa
    Park, Min-Chan
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (09) : 1630 - 1637
  • [46] Treatment of active ankylosing spondylitis with pamidronate
    Haibel, H
    Brandt, J
    Rudwaleit, M
    Soerensen, H
    Sieper, J
    Braun, J
    RHEUMATOLOGY, 2003, 42 (08)
  • [47] COST - EFFECTIVENESS STUDY OF ETANERCEPT AS FIRST LINE TREATMENT FOR ANKYLOSING SPONDYLITIS IN COLOMBIA
    Castano Gamboa, N.
    Reyes, J.
    Rodriguez, A.
    VALUE IN HEALTH, 2018, 21 : S294 - S294
  • [48] COST-EFFECTIVENESS ANALYSIS OF BIOLOGICS USED FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS IN CHINA
    Shi, J.
    Zhou, W.
    Wu, F.
    Lin, T.
    Hu, M.
    VALUE IN HEALTH, 2024, 27 (06) : S108 - S108
  • [49] Paradoxical plaque psoriasis due to secukinumab treatment in an ankylosing spondylitis patient
    Durmaz, Koray
    Ataseven, Arzu
    Ozer, Ilkay
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [50] Cost-effectiveness of infliximab for ankylosing spondylitis (AS) in Canada
    Kobelt, G
    Andlin-Sobocki, P
    Maksymowych, W
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 406 - 406
12345